[PHARMA] YoY Annualized Quarter Result on 30-Sep-2013 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- -25.17%
YoY- -50.63%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 2,141,608 2,012,216 1,994,440 1,838,372 1,773,256 1,537,593 1,336,309 8.17%
PBT 90,597 118,673 116,968 79,986 132,088 75,757 64,217 5.89%
Tax -28,252 -27,282 -40,162 -32,661 -37,856 -21,620 -21,201 4.89%
NP 62,345 91,390 76,805 47,325 94,232 54,137 43,016 6.37%
-
NP to SH 61,913 90,642 76,196 45,849 92,860 53,620 43,520 6.04%
-
Tax Rate 31.18% 22.99% 34.34% 40.83% 28.66% 28.54% 33.01% -
Total Cost 2,079,262 1,920,825 1,917,634 1,791,046 1,679,024 1,483,456 1,293,293 8.22%
-
Net Worth 530,907 534,070 507,513 473,857 496,623 464,307 424,715 3.78%
Dividend
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Div 44,889 79,389 55,239 33,903 39,227 - 67,041 -6.46%
Div Payout % 72.50% 87.59% 72.50% 73.95% 42.24% - 154.05% -
Equity
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Net Worth 530,907 534,070 507,513 473,857 496,623 464,307 424,715 3.78%
NOSH 258,979 258,880 258,935 258,938 117,683 106,983 106,981 15.86%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin 2.91% 4.54% 3.85% 2.57% 5.31% 3.52% 3.22% -
ROE 11.66% 16.97% 15.01% 9.68% 18.70% 11.55% 10.25% -
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 826.94 777.28 770.25 709.97 1,506.80 1,437.23 1,249.11 -6.63%
EPS 23.91 35.01 29.43 17.71 78.91 50.12 40.68 -8.46%
DPS 17.33 30.67 21.33 13.09 33.33 0.00 62.67 -19.26%
NAPS 2.05 2.063 1.96 1.83 4.22 4.34 3.97 -10.42%
Adjusted Per Share Value based on latest NOSH - 258,689
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 148.60 139.62 138.38 127.56 123.04 106.69 92.72 8.17%
EPS 4.30 6.29 5.29 3.18 6.44 3.72 3.02 6.06%
DPS 3.11 5.51 3.83 2.35 2.72 0.00 4.65 -6.47%
NAPS 0.3684 0.3706 0.3521 0.3288 0.3446 0.3222 0.2947 3.78%
Price Multiplier on Financial Quarter End Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 -
Price 5.58 6.50 4.63 4.82 7.55 5.90 4.98 -
P/RPS 0.67 0.84 0.60 0.68 0.50 0.41 0.40 8.96%
P/EPS 23.34 18.56 15.73 27.22 9.57 11.77 12.24 11.34%
EY 4.28 5.39 6.36 3.67 10.45 8.49 8.17 -10.20%
DY 3.11 4.72 4.61 2.72 4.42 0.00 12.58 -20.76%
P/NAPS 2.72 3.15 2.36 2.63 1.79 1.36 1.25 13.82%
Price Multiplier on Announcement Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 21/11/16 26/11/15 21/11/14 19/11/13 06/11/12 01/11/11 04/11/10 -
Price 5.70 6.50 4.45 4.72 8.25 5.90 4.92 -
P/RPS 0.69 0.84 0.58 0.66 0.55 0.41 0.39 9.96%
P/EPS 23.84 18.56 15.12 26.66 10.46 11.77 12.09 11.97%
EY 4.19 5.39 6.61 3.75 9.56 8.49 8.27 -10.70%
DY 3.04 4.72 4.79 2.77 4.04 0.00 12.74 -21.22%
P/NAPS 2.78 3.15 2.27 2.58 1.95 1.36 1.24 14.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment